Epitope Inc board director authorize three-for-one common stock split shareholder approval expect weeks. The company announce two-for-one split week board reconvene agree change three-for-one split. Epitope involve production monoclonal antibody diagnostic therapeutic AIDS immunological diseases. Reuter 